BenevolentAI
using our platform for societal bene a covid treatment now approved for use by the non commercial collaboration rapid novel effective focused on dengue fever a major burden aims to deliver biological targets and drug candidates experimental validation in progress assays benefit lilt | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
26 of 29
Similar slides by BenevolentAI
See diffirences between slides (animation)
Results
March 2023
using our platform for societal bene a covid treatment now approved for use by the non commercial collaboration rapid as a treatment in just hours published research in the lancet in novel our technology and work a previously unknown antiviral mechanism effective barrier trial showed reduces mortality by in patients and by in ventilated or patients focused on dengue fever a major burden aims to deliver biological targets and drug candidates experimental validation in progress assays approved the to treat covid in may after granting in led to equity investment from benefit lilt | BenevolentAI
Related slides by other companies
ATAI
Investor Day
January 2022
why are there no approved treatments for | ATAI
Erasca
Investor Presentation
November 2023
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
AstraZeneca
Investor Event
December 2022
leaders in breast cancer treatment | AstraZeneca
Ocuphire Pharma
Results
October 2022
has the potential to be first line of therapy for patients efficacy signal safety non invasive treatment option guidance physician patients efficacy signal safety non invasive treatment option | Ocuphire Pharma
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io